Melissa Etheridge, a Grammy Stage, and the Reality of Breast Cancer

On screen

In 2004, rock singer-songwriter Melissa Etheridge publicly shared that she had been diagnosed with breast cancer. She stepped away from touring for treatment. A few months later, in early 2005, she made a widely remembered return to the stage at the Grammy Awards, performing bald from chemotherapy — a public moment that many survivors have pointed to as a source of strength. She has continued to speak openly about her experience in the years since.

The reality

According to the National Cancer Institute, breast cancer is cancer that starts in the breast, and can begin in one or both breasts. It happens when cells in the breast grow without control, forming a mass called a tumor that may spread elsewhere in the body.

NCI explains that most breast cancers begin in glandular tissue — the milk ducts (ductal cancers) or the lobules that make milk (lobular cancers). Less commonly, breast cancer can start in the fibrous and fatty tissue, the nipple, or blood and lymph vessels.

NCI notes that when abnormal cells stay within the ducts or lobules and have not spread, it is called carcinoma in situ. Invasive cancers have grown into surrounding breast tissue and can reach nearby lymph nodes or other organs — and most breast cancers are invasive. Breast cancer mostly affects women aged 45 and older, though anyone with breasts can develop it; it is rare in children and men.

What the story gets right — and what to remember

Melissa Etheridge's Grammy performance put a very human face on treatment, including a common and visible side effect — hair loss from chemotherapy. It is a reminder that treatment can be demanding, and that people experience it in very individual ways.

Every diagnosis is different. The type of breast cancer, its stage, whether it has reached the lymph nodes, and the treatment plan all vary from person to person. One artist's public story can inspire and educate, but it is not medical advice and does not predict any individual's path.

Awareness, screening & prevention

The NCI says breast cancer screening looks for cancer in people without symptoms, and that screening has been found to reduce deaths from breast cancer. Mammography, an x-ray of the breast, is the standard screening test for most women.

NCI notes that women at high risk may be offered breast MRI along with mammography, and ultrasound is sometimes used, for example for dense breasts. NCI is clear that a clinical breast exam or self-exam alone is not an adequate screening test — but it encourages every woman to be aware of how her breasts normally feel and to tell a doctor about any unusual change. Because screening also has potential harms such as false positives, NCI recommends weighing benefits and tradeoffs with a healthcare team.

Turning a story into something useful

A story like Melissa Etheridge's can channel admiration into something practical: learning the facts, asking a healthcare provider about screening, and passing accurate information to friends and family. Free, trustworthy cancer education helps people face a diagnosis — their own or a loved one's — with more understanding and less fear.

Questions to ask a healthcare team

• When should I begin breast cancer screening, given my age and personal history?
• What should I do if I feel a lump or notice a change in my breast?
• If I need chemotherapy or radiation, what side effects are common and how are they managed?
• What support is available for the physical and emotional side of treatment?